ASSESSING THE PREDICTIVE PERFORMANCE OF HFA-PEFF AND H₂FPEF SCORES IN PATIENTS WITH SUSPECTED HEART FAILURE AND PRESERVED EJECTION FRACTION
PDF

Keywords

heart failure
HFA-PEFF
H₂FPEF

Abstract

Two scoring systems, HFA-PEFF and H₂FPEF, have been developed for the diagnosis of heart failure with preserved ejection fraction (HFpEF) and have also demonstrated prognostic value in individuals with exertional dyspnea. A total of 69 patients suspected of having HFpEF, based on clinical symptoms and transthoracic echocardiography, were included and monitored for 12-18 month. Both HFA-PEFF and H₂FPEF scores were calculated upon enrolment, and patients were classified as having intermediate or low risk based on these scores. During the monitoring period, 27 patients (39% of the cohort) experienced cardiac decompensation.  Receiver operating characteristic (ROC) analysis showed that both scoring systems can predict cardiac decompensation in patients with suspected HFpEF, with an area under the curve (AUC) of 0.730 for the HFA-PEFF score and 0.720 for the H₂FPEF score. Univariate logistic regression analysis revealed that patients with an HFA-PEFF score of ≥ 3.5 had an Odds Ratio (OR) of 7.60 for cardiac decompensation, while those with an H₂FPEF score of ≥ 3.5 had an OR of 6.87 for cardiac decompensation. In the multivariate analysis, both scores remained predictive, with ORs of 5.07 for HFA-PEFF and 4.65 for H₂FPEF for cardiac decompensation. The confusion matrices showed accuracies of approximately 67.74% for HFA-PEFF and 64% for H₂FPEF in predicting the cardiac decompensation. When both scores were combined, their accuracy was also 67.74%. In conclusion, both the HFA-PEFF and H2FPEF scoring systems demonstrated moderate predictive value in assessing the risk of cardiac decompensation in patients suspected of HFpEF, maintaining their significance in multivariate analysis.

https://doi.org/10.56051/tils.v4i1.18
PDF

References

van Riet EE, Hoes AW, Wagenaar KP, Limburg A, Landman MA, Rutten FH. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016;18:242–252.

Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham heart study of the national heart, lung, and blood institute. Circulation. 2009; 119:3070–7

Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355:251–9

Lindenfeld J, Albert NM, Boehmer JPHFSA, et al. Comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1–194.

Redfield MM. Heart failure with preserved ejection fraction. N Engl J Med. 2017;376(9):897.

Pieske B, Tschope C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Seferovic P, Filippatos G. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2019;40:3297-3317.

Shah SJ, Borlaug BA, Kitzman DW, et al. Research priorities for heart failure with preserved ejection fraction: National Heart, Lung, and Blood Institute Working Group summary. Circulation. 2020;141(12):1001-1026.

Obokata M, Kane GC, Reddy YN, Olson TP, Melenovsky V, Borlaug BA. Role of diastolic stresstesting in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study.Circulation. 2017;135(9):825-838.

Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016; 29(4):277-314.

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation 2018;138:861-870.

Barandiarán Aizpurua A, Sanders-van Wijk S, Brunner-La Rocca HP, Henkens M, Heymans S, Beussink-Nelson L, Shah SJ, van Empel VPM. Validation of the HFA-PEFF score for the diagnosis of heart failure with preserved ejection fraction. Eur J Heart Fail. 2020 Mar;22(3):413-421.

Sepehrvand N, Alemayehu W, Dyck GJB, Dyck JRB, Anderson T, Howlett J, Paterson I, McAlister FA, Ezekowitz JA. External validation of the H2F-PEF model in diagnosing patients with heart failure and preserved ejection fraction.Circulation 2019;139:2377-2379.

Selvaraj S, Myhre PL, Vaduganathan M, Claggett BL, Matsushita K, Kitzman DW, Borlaug BA, Shah AM, Solomon SD. Application of Diagnostic Algorithms for Heart Failure with Preserved Ejection Fraction to the Community. JACC Heart Fail. 2020 Aug;8(8):640-653.

Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015 Jan;28(1):1–39.e14.

Ponikowski P,Voors A, Anker S, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016 Aug;18(8):891-975.

Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743.

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012;33:1750 –1757.

Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ. Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model. Clin Epidemiol. 2020 Jun 15;12: 607-616.

Brann A, Miller J, Eshraghian E, Park JJ, Greenberg B. Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2023 Oct;25(10):1755-1765.

Sun Y, Si J, Li J, Dai M, King E, Zhang X, Zhang Y, Xia Y, Tse G, Liu Y. Predictive Value of HFA-PEFF Score in Patients With Heart Failure With Preserved Ejection Fraction. Front Cardiovasc Med. 2021 Oct 29;8: 656536.

Sueta D, Yamamoto E, Nishihara T, Tokitsu T, Fujisue K, Oike F, Takae M, Usuku H, Takashio S, Arima Y, Suzuki S, Nakamura T, Ito M, Kanazawa H, Sakamoto K, Kaikita K, Tsujita K. H2FPEF Score as a Prognostic Value in HFpEF Patients. Am J Hypertens. 2019 Oct 16;32(11):1082-1090.

Ouwerkerk W, Tromp J, Jin X, Jaufeerally F, Yeo PSD, Leong KTG, et al. Heart Failure with Preserved Ejection Fraction Diagnostic Scores in an Asian Population. Eur J Heart Fail. 2020;22(9):1737-9.

Tada A, Nagai T, Omote K, Iwano H, Tsujinaga S, Kamiya K, et al. Performance of the H2FPEF and the HFA-PEFF Scores for the Diagnosis of Heart Failure with Preserved Ejection Fraction in Japanese Patients: A Report from the Japanese Multicenter Registry. Int J Cardiol.2021;342:43-8.

Wijk SS, Barandiarán Aizpurua A, Brunner-La Rocca HP, Henkens MTHM, Weerts J, Knackstedt C, et al. The HFA-PEFF and H2 FPEF Scores Largely Disagree in Classifying Patients with Suspected Heart Failure with Preserved Ejection Fraction. Eur J Heart Fail. 2021;23(5):838-40.

Reddy YNV, Kaye DM, Handoko ML, van de Bovenkamp AA, Tedford RJ, Keck C, et al. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea. JAMA Cardiol.2022;7(9):891-9.

Churchill TW, Li SX, Curreri L, Zern EK, Lau ES, Liu EE, et al. Evaluation of 2 Existing Diagnostic Scores for Heart Failure With Preserved Ejection Fraction Against a Comprehensively Phenotyped Cohort. Circulation.2021;143(3):289-91.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Copyright (c) 2025 Ileana Monica Stoian, Alexandru Scafa-Udriște, Lucian Calmac, Maria Dorobanțu